Pfizer Inc.

Pfizer to offer low-cost medicines, vaccines to poor nations

3:35 a.m. May 25, 2022

- Associated Press

Here are the five dumbest ways you could have gotten rich in 2021

9:57 a.m. Nov. 2, 2021

- Barbara Kollmeyer

Here’s what could turn a ‘breather’ for stocks into a bigger correction

9:45 a.m. July 6, 2021

- Barbara Kollmeyer

Norway may drop AstraZeneca, J&J vaccines; EU will not take AstraZeneca one after June

8:14 a.m. May 10, 2021

- Lina Saigol

BioNTech shares soar 8% as COVID-19 vaccines drive revenue surge

7:50 a.m. May 10, 2021

- Jack Denton

EU proposes tougher controls on COVID-19 vaccine exports as supply row deepens

1:57 p.m. March 24, 2021

- Callum Keown

FTSE 100 flattens amid earnings tug of war between Vodafone and GlaxoSmithKline

11:48 a.m. Feb. 3, 2021

- Barbara Kollmeyer

Pfizer–BioNTech partnership pledges 75 million more vaccine doses to help ease the EU bloc’s shortage

2:19 p.m. Feb. 1, 2021

EU threatens legal action to secure more doses as vaccine shortage reaches crisis point

4:13 p.m. Jan. 29, 2021

European stocks and U.S. futures drop as GameStop-fueled volatility and COVID-19 worries drag on markets

6:28 a.m. Jan. 29, 2021

- Barbara Kollmeyer

AstraZeneca vaccine should only be given to under-65s, Germany recommends as EU shortage crisis deepens

12:20 p.m. Jan. 28, 2021

- Lina Saigol

Sanofi teams up with BioNTech and Pfizer to help fix Europe’s vaccine shortage

4:33 p.m. Jan. 27, 2021

- Lina Saigol

Open all hours: Round-the-clock vaccination sites to be piloted in England in COVID-19 drive

4:31 p.m. Jan. 19, 2021

- Lina Saigol

Fauci says two more COVID-19 vaccines could be approved within ‘weeks’

3:49 a.m. Jan. 18, 2021

European stocks trade higher as investors welcome U.S. stimulus package and Brexit deal

10:53 a.m. Dec. 28, 2020

- Barbara Kollmeyer

How Boris Johnson is navigating through the crisis over mutant COVID strain and travel ban

3:13 p.m. Dec. 21, 2020

- Lina Saigol

New COVID-19 vaccine candidate Valneva starts clinical trials

11:24 a.m. Dec. 17, 2020

CureVac starts Phase 3 clinical trial of its COVID-19 vaccine candidate

2:55 p.m. Dec. 14, 2020

European stocks climb on COVID-19 vaccine optimism and stimulus-deal hopes

11:45 a.m. Dec. 14, 2020

- Barbara Kollmeyer

With Brexit talks on the line, London stocks and the pound simultaneously suffer

12:46 p.m. Dec. 11, 2020

- Barbara Kollmeyer